Legend Biotech (LEGN) Non-cash Items (2020 - 2022)
Legend Biotech (LEGN) reported Non-cash Items of -$64.4 million for Q1 2022, up 11.87% on a YoY basis from -$57.6 million in Q1 2021, and up 72.25% quarter-over-quarter from -$232.1 million in Q3 2021.
Legend Biotech (LEGN) Non-cash Items (2020 - 2022) Analysis & Trends
Legend Biotech has reported Non-cash Items for 3 years, with the latest figure at -$64.4 million in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -64.41 Mn |
| Mar 31, 2022 | -64.41 Mn |
| Sep 30, 2021 | -232.14 Mn |
| Sep 30, 2021 | -232.14 Mn |
| Jun 30, 2021 | -154.80 Mn |
| Jun 30, 2021 | -154.80 Mn |
| Mar 31, 2021 | -73.08 Mn |
| Mar 31, 2021 | -73.08 Mn |
| Sep 30, 2020 | -157.24 Mn |
| Sep 30, 2020 | -157.24 Mn |
| Jun 30, 2020 | -94.74 Mn |
| Jun 30, 2020 | -94.74 Mn |